nodes	percent_of_prediction	percent_of_DWPC	metapath
Ponatinib—ABCB11—Verapamil—migraine	0.0999	0.166	CbGbCtD
Ponatinib—ABCG2—Verapamil—migraine	0.0475	0.0791	CbGbCtD
Ponatinib—CYP3A5—Propranolol—migraine	0.0383	0.0639	CbGbCtD
Ponatinib—CYP3A5—Amitriptyline—migraine	0.0332	0.0552	CbGbCtD
Ponatinib—CYP2C8—Amitriptyline—migraine	0.0319	0.0531	CbGbCtD
Ponatinib—CYP3A5—Valproic Acid—migraine	0.0302	0.0503	CbGbCtD
Ponatinib—CYP2C8—Valproic Acid—migraine	0.0291	0.0484	CbGbCtD
Ponatinib—ABCB1—Timolol—migraine	0.028	0.0466	CbGbCtD
Ponatinib—CYP2D6—Timolol—migraine	0.0264	0.0439	CbGbCtD
Ponatinib—CYP3A5—Verapamil—migraine	0.0263	0.0438	CbGbCtD
Ponatinib—CYP2C8—Verapamil—migraine	0.0253	0.0421	CbGbCtD
Ponatinib—ABCB1—Propranolol—migraine	0.025	0.0416	CbGbCtD
Ponatinib—CYP2D6—Propranolol—migraine	0.0235	0.0392	CbGbCtD
Ponatinib—ABCB1—Amitriptyline—migraine	0.0216	0.036	CbGbCtD
Ponatinib—CYP2D6—Amitriptyline—migraine	0.0203	0.0339	CbGbCtD
Ponatinib—ABCB1—Verapamil—migraine	0.0171	0.0285	CbGbCtD
Ponatinib—CYP2D6—Verapamil—migraine	0.0161	0.0269	CbGbCtD
Ponatinib—CYP3A4—Propranolol—migraine	0.015	0.0249	CbGbCtD
Ponatinib—CYP3A4—Amitriptyline—migraine	0.0129	0.0215	CbGbCtD
Ponatinib—CYP3A4—Valproic Acid—migraine	0.0118	0.0196	CbGbCtD
Ponatinib—CYP3A4—Topiramate—migraine	0.0106	0.0177	CbGbCtD
Ponatinib—CYP3A4—Verapamil—migraine	0.0103	0.0171	CbGbCtD
Ponatinib—FGFR3—skull—migraine	0.00885	0.0818	CbGeAlD
Ponatinib—FGFR2—skull—migraine	0.0058	0.0535	CbGeAlD
Ponatinib—RET—autonomic nervous system—migraine	0.00571	0.0528	CbGeAlD
Ponatinib—FGFR4—brainstem—migraine	0.00293	0.0271	CbGeAlD
Ponatinib—TEK—blood vessel—migraine	0.0023	0.0212	CbGeAlD
Ponatinib—SRC—blood vessel—migraine	0.00204	0.0189	CbGeAlD
Ponatinib—BCR—trigeminal ganglion—migraine	0.00196	0.0181	CbGeAlD
Ponatinib—KDR—blood vessel—migraine	0.00188	0.0174	CbGeAlD
Ponatinib—RET—neck—migraine	0.00181	0.0167	CbGeAlD
Ponatinib—FGFR1—trigeminal ganglion—migraine	0.00174	0.0161	CbGeAlD
Ponatinib—FGFR2—neck—migraine	0.00172	0.0158	CbGeAlD
Ponatinib—KIT—blood vessel—migraine	0.00167	0.0154	CbGeAlD
Ponatinib—FGFR4—head—migraine	0.00162	0.015	CbGeAlD
Ponatinib—RET—trigeminal ganglion—migraine	0.00156	0.0144	CbGeAlD
Ponatinib—LCK—trigeminal ganglion—migraine	0.00156	0.0144	CbGeAlD
Ponatinib—FGFR4—nervous system—migraine	0.00154	0.0142	CbGeAlD
Ponatinib—FGFR4—central nervous system—migraine	0.00148	0.0137	CbGeAlD
Ponatinib—FGFR4—cerebellum—migraine	0.00145	0.0134	CbGeAlD
Ponatinib—TEK—trigeminal ganglion—migraine	0.00142	0.0131	CbGeAlD
Ponatinib—FLT3—cardiovascular system—migraine	0.0014	0.013	CbGeAlD
Ponatinib—KDR—neck—migraine	0.00134	0.0124	CbGeAlD
Ponatinib—FGFR2—brainstem—migraine	0.00131	0.0121	CbGeAlD
Ponatinib—KIT—neck—migraine	0.00119	0.011	CbGeAlD
Ponatinib—FGFR4—brain—migraine	0.00118	0.0109	CbGeAlD
Ponatinib—KDR—trigeminal ganglion—migraine	0.00116	0.0107	CbGeAlD
Ponatinib—LYN—head—migraine	0.00111	0.0103	CbGeAlD
Ponatinib—FGFR3—head—migraine	0.00111	0.0102	CbGeAlD
Ponatinib—FGFR2—cardiovascular system—migraine	0.00107	0.00988	CbGeAlD
Ponatinib—LYN—nervous system—migraine	0.00105	0.00974	CbGeAlD
Ponatinib—FGFR3—nervous system—migraine	0.00105	0.00969	CbGeAlD
Ponatinib—KIT—trigeminal ganglion—migraine	0.00103	0.0095	CbGeAlD
Ponatinib—TEK—cardiovascular system—migraine	0.00103	0.00947	CbGeAlD
Ponatinib—LYN—central nervous system—migraine	0.00102	0.00938	CbGeAlD
Ponatinib—FGFR3—central nervous system—migraine	0.00101	0.00933	CbGeAlD
Ponatinib—FGFR3—cerebellum—migraine	0.000987	0.00912	CbGeAlD
Ponatinib—BCR—head—migraine	0.000958	0.00884	CbGeAlD
Ponatinib—PDGFRA—cardiovascular system—migraine	0.000929	0.00858	CbGeAlD
Ponatinib—SRC—cardiovascular system—migraine	0.000911	0.00842	CbGeAlD
Ponatinib—KIT—brainstem—migraine	0.00091	0.00841	CbGeAlD
Ponatinib—BCR—nervous system—migraine	0.000908	0.00838	CbGeAlD
Ponatinib—ABL1—trigeminal ganglion—migraine	0.000895	0.00827	CbGeAlD
Ponatinib—BCR—central nervous system—migraine	0.000874	0.00807	CbGeAlD
Ponatinib—BCR—cerebellum—migraine	0.000854	0.00789	CbGeAlD
Ponatinib—FLT3—cerebellum—migraine	0.000848	0.00783	CbGeAlD
Ponatinib—KDR—cardiovascular system—migraine	0.000838	0.00774	CbGeAlD
Ponatinib—LYN—brain—migraine	0.000806	0.00745	CbGeAlD
Ponatinib—FGFR3—brain—migraine	0.000802	0.00741	CbGeAlD
Ponatinib—ABL1—brainstem—migraine	0.000792	0.00732	CbGeAlD
Ponatinib—RET—head—migraine	0.000762	0.00704	CbGeAlD
Ponatinib—FGFR1—cerebellum—migraine	0.00076	0.00702	CbGeAlD
Ponatinib—KIT—cardiovascular system—migraine	0.000743	0.00686	CbGeAlD
Ponatinib—FGFR2—head—migraine	0.000724	0.00669	CbGeAlD
Ponatinib—RET—nervous system—migraine	0.000723	0.00668	CbGeAlD
Ponatinib—RET—central nervous system—migraine	0.000696	0.00643	CbGeAlD
Ponatinib—TEK—head—migraine	0.000695	0.00641	CbGeAlD
Ponatinib—BCR—brain—migraine	0.000694	0.00641	CbGeAlD
Ponatinib—FGFR2—nervous system—migraine	0.000687	0.00634	CbGeAlD
Ponatinib—RET—cerebellum—migraine	0.00068	0.00628	CbGeAlD
Ponatinib—FGFR2—central nervous system—migraine	0.000661	0.00611	CbGeAlD
Ponatinib—TEK—nervous system—migraine	0.000658	0.00608	CbGeAlD
Ponatinib—ABL1—cardiovascular system—migraine	0.000647	0.00597	CbGeAlD
Ponatinib—FGFR2—cerebellum—migraine	0.000646	0.00597	CbGeAlD
Ponatinib—TEK—central nervous system—migraine	0.000634	0.00586	CbGeAlD
Ponatinib—PDGFRA—head—migraine	0.000629	0.00581	CbGeAlD
Ponatinib—TEK—cerebellum—migraine	0.00062	0.00572	CbGeAlD
Ponatinib—FGFR1—brain—migraine	0.000617	0.0057	CbGeAlD
Ponatinib—SRC—head—migraine	0.000617	0.0057	CbGeAlD
Ponatinib—PDGFRA—nervous system—migraine	0.000597	0.00551	CbGeAlD
Ponatinib—SRC—nervous system—migraine	0.000585	0.0054	CbGeAlD
Ponatinib—PDGFRA—central nervous system—migraine	0.000574	0.0053	CbGeAlD
Ponatinib—KDR—head—migraine	0.000568	0.00524	CbGeAlD
Ponatinib—ABCG2—trigeminal ganglion—migraine	0.000565	0.00522	CbGeAlD
Ponatinib—SRC—central nervous system—migraine	0.000563	0.0052	CbGeAlD
Ponatinib—PDGFRA—cerebellum—migraine	0.000561	0.00518	CbGeAlD
Ponatinib—RET—brain—migraine	0.000553	0.0051	CbGeAlD
Ponatinib—SRC—cerebellum—migraine	0.000551	0.00508	CbGeAlD
Ponatinib—KDR—nervous system—migraine	0.000538	0.00497	CbGeAlD
Ponatinib—FGFR2—brain—migraine	0.000525	0.00485	CbGeAlD
Ponatinib—KDR—central nervous system—migraine	0.000518	0.00479	CbGeAlD
Ponatinib—KDR—cerebellum—migraine	0.000506	0.00468	CbGeAlD
Ponatinib—TEK—brain—migraine	0.000503	0.00465	CbGeAlD
Ponatinib—KIT—head—migraine	0.000503	0.00465	CbGeAlD
Ponatinib—KIT—nervous system—migraine	0.000477	0.0044	CbGeAlD
Ponatinib—KIT—central nervous system—migraine	0.000459	0.00424	CbGeAlD
Ponatinib—PDGFRA—brain—migraine	0.000456	0.00421	CbGeAlD
Ponatinib—ABCB1—blood vessel—migraine	0.000451	0.00416	CbGeAlD
Ponatinib—KIT—cerebellum—migraine	0.000449	0.00414	CbGeAlD
Ponatinib—SRC—brain—migraine	0.000447	0.00413	CbGeAlD
Ponatinib—ABL1—head—migraine	0.000438	0.00404	CbGeAlD
Ponatinib—ABL1—nervous system—migraine	0.000415	0.00383	CbGeAlD
Ponatinib—KDR—brain—migraine	0.000411	0.0038	CbGeAlD
Ponatinib—ABL1—central nervous system—migraine	0.0004	0.00369	CbGeAlD
Ponatinib—ABL1—cerebellum—migraine	0.000391	0.00361	CbGeAlD
Ponatinib—KIT—brain—migraine	0.000365	0.00337	CbGeAlD
Ponatinib—CYP2D6—brainstem—migraine	0.000343	0.00316	CbGeAlD
Ponatinib—Stomatitis—Gabapentin—migraine	0.000337	0.00149	CcSEcCtD
Ponatinib—Jaundice—Gabapentin—migraine	0.000337	0.00149	CcSEcCtD
Ponatinib—Paraesthesia—Verapamil—migraine	0.000337	0.00149	CcSEcCtD
Ponatinib—Urinary tract infection—Gabapentin—migraine	0.000336	0.00149	CcSEcCtD
Ponatinib—Chills—Valproic Acid—migraine	0.000336	0.00149	CcSEcCtD
Ponatinib—Arrhythmia—Valproic Acid—migraine	0.000335	0.00148	CcSEcCtD
Ponatinib—Dyspnoea—Verapamil—migraine	0.000335	0.00148	CcSEcCtD
Ponatinib—Gastrointestinal pain—Propranolol—migraine	0.000334	0.00148	CcSEcCtD
Ponatinib—Alanine aminotransferase increased—Topiramate—migraine	0.000333	0.00148	CcSEcCtD
Ponatinib—Dizziness—Amitriptyline—migraine	0.000331	0.00147	CcSEcCtD
Ponatinib—Alopecia—Valproic Acid—migraine	0.000331	0.00147	CcSEcCtD
Ponatinib—Dyspepsia—Verapamil—migraine	0.00033	0.00146	CcSEcCtD
Ponatinib—Abdominal distension—Topiramate—migraine	0.000328	0.00146	CcSEcCtD
Ponatinib—Oedema peripheral—Timolol—migraine	0.000328	0.00146	CcSEcCtD
Ponatinib—Mental disorder—Valproic Acid—migraine	0.000328	0.00145	CcSEcCtD
Ponatinib—Connective tissue disorder—Timolol—migraine	0.000328	0.00145	CcSEcCtD
Ponatinib—Hepatobiliary disease—Gabapentin—migraine	0.000327	0.00145	CcSEcCtD
Ponatinib—Epistaxis—Gabapentin—migraine	0.000326	0.00145	CcSEcCtD
Ponatinib—Malnutrition—Valproic Acid—migraine	0.000326	0.00144	CcSEcCtD
Ponatinib—Fatigue—Verapamil—migraine	0.000323	0.00143	CcSEcCtD
Ponatinib—Abdominal pain—Propranolol—migraine	0.000322	0.00143	CcSEcCtD
Ponatinib—Body temperature increased—Propranolol—migraine	0.000322	0.00143	CcSEcCtD
Ponatinib—Visual impairment—Timolol—migraine	0.000321	0.00142	CcSEcCtD
Ponatinib—Constipation—Verapamil—migraine	0.000321	0.00142	CcSEcCtD
Ponatinib—Pain—Verapamil—migraine	0.000321	0.00142	CcSEcCtD
Ponatinib—Pancreatitis—Topiramate—migraine	0.00032	0.00142	CcSEcCtD
Ponatinib—Vomiting—Amitriptyline—migraine	0.000319	0.00141	CcSEcCtD
Ponatinib—Angina pectoris—Topiramate—migraine	0.000318	0.00141	CcSEcCtD
Ponatinib—ABL1—brain—migraine	0.000317	0.00293	CbGeAlD
Ponatinib—Rash—Amitriptyline—migraine	0.000316	0.0014	CcSEcCtD
Ponatinib—Dermatitis—Amitriptyline—migraine	0.000316	0.0014	CcSEcCtD
Ponatinib—Back pain—Valproic Acid—migraine	0.000315	0.0014	CcSEcCtD
Ponatinib—Headache—Amitriptyline—migraine	0.000314	0.00139	CcSEcCtD
Ponatinib—Muscle spasms—Valproic Acid—migraine	0.000313	0.00139	CcSEcCtD
Ponatinib—Abdominal discomfort—Topiramate—migraine	0.000313	0.00139	CcSEcCtD
Ponatinib—Eye disorder—Timolol—migraine	0.000312	0.00138	CcSEcCtD
Ponatinib—Haemorrhage—Gabapentin—migraine	0.00031	0.00138	CcSEcCtD
Ponatinib—Pancytopenia—Topiramate—migraine	0.00031	0.00137	CcSEcCtD
Ponatinib—Cardiac disorder—Timolol—migraine	0.000309	0.00137	CcSEcCtD
Ponatinib—Hypoaesthesia—Gabapentin—migraine	0.000309	0.00137	CcSEcCtD
Ponatinib—Vision blurred—Valproic Acid—migraine	0.000307	0.00136	CcSEcCtD
Ponatinib—Oedema peripheral—Gabapentin—migraine	0.000306	0.00136	CcSEcCtD
Ponatinib—Neutropenia—Topiramate—migraine	0.000305	0.00135	CcSEcCtD
Ponatinib—Connective tissue disorder—Gabapentin—migraine	0.000305	0.00135	CcSEcCtD
Ponatinib—Upper respiratory tract infection—Topiramate—migraine	0.000303	0.00134	CcSEcCtD
Ponatinib—Angiopathy—Timolol—migraine	0.000302	0.00134	CcSEcCtD
Ponatinib—Anaemia—Valproic Acid—migraine	0.000301	0.00134	CcSEcCtD
Ponatinib—Erectile dysfunction—Topiramate—migraine	0.000301	0.00133	CcSEcCtD
Ponatinib—Mediastinal disorder—Timolol—migraine	0.0003	0.00133	CcSEcCtD
Ponatinib—Visual impairment—Gabapentin—migraine	0.000299	0.00133	CcSEcCtD
Ponatinib—Arrhythmia—Timolol—migraine	0.000298	0.00132	CcSEcCtD
Ponatinib—Nausea—Amitriptyline—migraine	0.000298	0.00132	CcSEcCtD
Ponatinib—Weight decreased—Topiramate—migraine	0.000295	0.00131	CcSEcCtD
Ponatinib—Alopecia—Timolol—migraine	0.000295	0.00131	CcSEcCtD
Ponatinib—Hyperglycaemia—Topiramate—migraine	0.000294	0.0013	CcSEcCtD
Ponatinib—Asthenia—Propranolol—migraine	0.000293	0.0013	CcSEcCtD
Ponatinib—Pneumonia—Topiramate—migraine	0.000293	0.0013	CcSEcCtD
Ponatinib—Mental disorder—Timolol—migraine	0.000292	0.00129	CcSEcCtD
Ponatinib—Leukopenia—Valproic Acid—migraine	0.000292	0.00129	CcSEcCtD
Ponatinib—Infestation—Topiramate—migraine	0.000291	0.00129	CcSEcCtD
Ponatinib—Infestation NOS—Topiramate—migraine	0.000291	0.00129	CcSEcCtD
Ponatinib—Malnutrition—Timolol—migraine	0.00029	0.00129	CcSEcCtD
Ponatinib—Erythema—Timolol—migraine	0.00029	0.00129	CcSEcCtD
Ponatinib—Eye disorder—Gabapentin—migraine	0.00029	0.00129	CcSEcCtD
Ponatinib—Cardiac disorder—Gabapentin—migraine	0.000288	0.00128	CcSEcCtD
Ponatinib—Neuropathy peripheral—Topiramate—migraine	0.000285	0.00126	CcSEcCtD
Ponatinib—Cough—Valproic Acid—migraine	0.000284	0.00126	CcSEcCtD
Ponatinib—Stomatitis—Topiramate—migraine	0.000284	0.00126	CcSEcCtD
Ponatinib—Urinary tract infection—Topiramate—migraine	0.000283	0.00125	CcSEcCtD
Ponatinib—Hypertension—Valproic Acid—migraine	0.000281	0.00125	CcSEcCtD
Ponatinib—Mediastinal disorder—Gabapentin—migraine	0.00028	0.00124	CcSEcCtD
Ponatinib—Diarrhoea—Propranolol—migraine	0.000279	0.00124	CcSEcCtD
Ponatinib—Chills—Gabapentin—migraine	0.000279	0.00123	CcSEcCtD
Ponatinib—ABCB1—trigeminal ganglion—migraine	0.000278	0.00257	CbGeAlD
Ponatinib—Arthralgia—Valproic Acid—migraine	0.000278	0.00123	CcSEcCtD
Ponatinib—Myalgia—Valproic Acid—migraine	0.000278	0.00123	CcSEcCtD
Ponatinib—Unspecified disorder of skin and subcutaneous tissue—Valproic Acid—migraine	0.000276	0.00122	CcSEcCtD
Ponatinib—Epistaxis—Topiramate—migraine	0.000274	0.00122	CcSEcCtD
Ponatinib—Alopecia—Gabapentin—migraine	0.000274	0.00122	CcSEcCtD
Ponatinib—Vision blurred—Timolol—migraine	0.000273	0.00121	CcSEcCtD
Ponatinib—Mental disorder—Gabapentin—migraine	0.000272	0.00121	CcSEcCtD
Ponatinib—Dry mouth—Valproic Acid—migraine	0.000271	0.0012	CcSEcCtD
Ponatinib—Erythema—Gabapentin—migraine	0.00027	0.0012	CcSEcCtD
Ponatinib—Malnutrition—Gabapentin—migraine	0.00027	0.0012	CcSEcCtD
Ponatinib—Dizziness—Propranolol—migraine	0.00027	0.0012	CcSEcCtD
Ponatinib—Asthenia—Verapamil—migraine	0.000269	0.00119	CcSEcCtD
Ponatinib—Oedema—Valproic Acid—migraine	0.000266	0.00118	CcSEcCtD
Ponatinib—Pruritus—Verapamil—migraine	0.000265	0.00118	CcSEcCtD
Ponatinib—Infection—Valproic Acid—migraine	0.000264	0.00117	CcSEcCtD
Ponatinib—Haemoglobin—Topiramate—migraine	0.000262	0.00116	CcSEcCtD
Ponatinib—Back pain—Gabapentin—migraine	0.000261	0.00116	CcSEcCtD
Ponatinib—Haemorrhage—Topiramate—migraine	0.000261	0.00116	CcSEcCtD
Ponatinib—Nervous system disorder—Valproic Acid—migraine	0.000261	0.00116	CcSEcCtD
Ponatinib—Thrombocytopenia—Valproic Acid—migraine	0.00026	0.00115	CcSEcCtD
Ponatinib—Hypoaesthesia—Topiramate—migraine	0.00026	0.00115	CcSEcCtD
Ponatinib—Muscle spasms—Gabapentin—migraine	0.00026	0.00115	CcSEcCtD
Ponatinib—Vomiting—Propranolol—migraine	0.000259	0.00115	CcSEcCtD
Ponatinib—Skin disorder—Valproic Acid—migraine	0.000258	0.00115	CcSEcCtD
Ponatinib—Oedema peripheral—Topiramate—migraine	0.000257	0.00114	CcSEcCtD
Ponatinib—Hyperhidrosis—Valproic Acid—migraine	0.000257	0.00114	CcSEcCtD
Ponatinib—Rash—Propranolol—migraine	0.000257	0.00114	CcSEcCtD
Ponatinib—Dermatitis—Propranolol—migraine	0.000257	0.00114	CcSEcCtD
Ponatinib—Diarrhoea—Verapamil—migraine	0.000257	0.00114	CcSEcCtD
Ponatinib—Connective tissue disorder—Topiramate—migraine	0.000257	0.00114	CcSEcCtD
Ponatinib—Vision blurred—Gabapentin—migraine	0.000255	0.00113	CcSEcCtD
Ponatinib—Cough—Timolol—migraine	0.000253	0.00112	CcSEcCtD
Ponatinib—Visual impairment—Topiramate—migraine	0.000252	0.00112	CcSEcCtD
Ponatinib—Hypertension—Timolol—migraine	0.000251	0.00111	CcSEcCtD
Ponatinib—Anaemia—Gabapentin—migraine	0.00025	0.00111	CcSEcCtD
Ponatinib—Dizziness—Verapamil—migraine	0.000248	0.0011	CcSEcCtD
Ponatinib—Myalgia—Timolol—migraine	0.000247	0.0011	CcSEcCtD
Ponatinib—Arthralgia—Timolol—migraine	0.000247	0.0011	CcSEcCtD
Ponatinib—ABCG2—cerebellum—migraine	0.000246	0.00228	CbGeAlD
Ponatinib—Unspecified disorder of skin and subcutaneous tissue—Timolol—migraine	0.000245	0.00109	CcSEcCtD
Ponatinib—Eye disorder—Topiramate—migraine	0.000244	0.00108	CcSEcCtD
Ponatinib—Musculoskeletal discomfort—Valproic Acid—migraine	0.000242	0.00107	CcSEcCtD
Ponatinib—Cardiac disorder—Topiramate—migraine	0.000242	0.00107	CcSEcCtD
Ponatinib—Flushing—Topiramate—migraine	0.000242	0.00107	CcSEcCtD
Ponatinib—Nausea—Propranolol—migraine	0.000242	0.00107	CcSEcCtD
Ponatinib—Leukopenia—Gabapentin—migraine	0.000242	0.00107	CcSEcCtD
Ponatinib—Dry mouth—Timolol—migraine	0.000242	0.00107	CcSEcCtD
Ponatinib—Insomnia—Valproic Acid—migraine	0.000241	0.00107	CcSEcCtD
Ponatinib—Paraesthesia—Valproic Acid—migraine	0.000239	0.00106	CcSEcCtD
Ponatinib—Vomiting—Verapamil—migraine	0.000239	0.00106	CcSEcCtD
Ponatinib—Dyspnoea—Valproic Acid—migraine	0.000237	0.00105	CcSEcCtD
Ponatinib—Angiopathy—Topiramate—migraine	0.000237	0.00105	CcSEcCtD
Ponatinib—Oedema—Timolol—migraine	0.000237	0.00105	CcSEcCtD
Ponatinib—Rash—Verapamil—migraine	0.000237	0.00105	CcSEcCtD
Ponatinib—Dermatitis—Verapamil—migraine	0.000236	0.00105	CcSEcCtD
Ponatinib—Cough—Gabapentin—migraine	0.000236	0.00105	CcSEcCtD
Ponatinib—Mediastinal disorder—Topiramate—migraine	0.000235	0.00104	CcSEcCtD
Ponatinib—Infection—Timolol—migraine	0.000235	0.00104	CcSEcCtD
Ponatinib—Headache—Verapamil—migraine	0.000235	0.00104	CcSEcCtD
Ponatinib—Chills—Topiramate—migraine	0.000234	0.00104	CcSEcCtD
Ponatinib—Dyspepsia—Valproic Acid—migraine	0.000234	0.00104	CcSEcCtD
Ponatinib—Hypertension—Gabapentin—migraine	0.000233	0.00103	CcSEcCtD
Ponatinib—Nervous system disorder—Timolol—migraine	0.000232	0.00103	CcSEcCtD
Ponatinib—Decreased appetite—Valproic Acid—migraine	0.000231	0.00103	CcSEcCtD
Ponatinib—Alopecia—Topiramate—migraine	0.000231	0.00102	CcSEcCtD
Ponatinib—Arthralgia—Gabapentin—migraine	0.00023	0.00102	CcSEcCtD
Ponatinib—Myalgia—Gabapentin—migraine	0.00023	0.00102	CcSEcCtD
Ponatinib—Skin disorder—Timolol—migraine	0.00023	0.00102	CcSEcCtD
Ponatinib—Gastrointestinal disorder—Valproic Acid—migraine	0.00023	0.00102	CcSEcCtD
Ponatinib—Fatigue—Valproic Acid—migraine	0.000229	0.00102	CcSEcCtD
Ponatinib—Hyperhidrosis—Timolol—migraine	0.000229	0.00101	CcSEcCtD
Ponatinib—Mental disorder—Topiramate—migraine	0.000229	0.00101	CcSEcCtD
Ponatinib—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—migraine	0.000228	0.00101	CcSEcCtD
Ponatinib—Constipation—Valproic Acid—migraine	0.000228	0.00101	CcSEcCtD
Ponatinib—Pain—Valproic Acid—migraine	0.000228	0.00101	CcSEcCtD
Ponatinib—Malnutrition—Topiramate—migraine	0.000227	0.00101	CcSEcCtD
Ponatinib—Erythema—Topiramate—migraine	0.000227	0.00101	CcSEcCtD
Ponatinib—Dry mouth—Gabapentin—migraine	0.000225	0.000997	CcSEcCtD
Ponatinib—Nausea—Verapamil—migraine	0.000223	0.000988	CcSEcCtD
Ponatinib—Oedema—Gabapentin—migraine	0.000221	0.000978	CcSEcCtD
Ponatinib—Back pain—Topiramate—migraine	0.00022	0.000975	CcSEcCtD
Ponatinib—Infection—Gabapentin—migraine	0.000219	0.000971	CcSEcCtD
Ponatinib—Muscle spasms—Topiramate—migraine	0.000219	0.000969	CcSEcCtD
Ponatinib—Gastrointestinal pain—Valproic Acid—migraine	0.000218	0.000964	CcSEcCtD
Ponatinib—Nervous system disorder—Gabapentin—migraine	0.000216	0.000959	CcSEcCtD
Ponatinib—Thrombocytopenia—Gabapentin—migraine	0.000216	0.000957	CcSEcCtD
Ponatinib—Musculoskeletal discomfort—Timolol—migraine	0.000216	0.000956	CcSEcCtD
Ponatinib—Vision blurred—Topiramate—migraine	0.000214	0.00095	CcSEcCtD
Ponatinib—Skin disorder—Gabapentin—migraine	0.000214	0.000949	CcSEcCtD
Ponatinib—Insomnia—Timolol—migraine	0.000214	0.000949	CcSEcCtD
Ponatinib—Hyperhidrosis—Gabapentin—migraine	0.000213	0.000945	CcSEcCtD
Ponatinib—Paraesthesia—Timolol—migraine	0.000213	0.000943	CcSEcCtD
Ponatinib—Dyspnoea—Timolol—migraine	0.000211	0.000936	CcSEcCtD
Ponatinib—Body temperature increased—Valproic Acid—migraine	0.00021	0.000932	CcSEcCtD
Ponatinib—Abdominal pain—Valproic Acid—migraine	0.00021	0.000932	CcSEcCtD
Ponatinib—Anaemia—Topiramate—migraine	0.00021	0.000931	CcSEcCtD
Ponatinib—Dyspepsia—Timolol—migraine	0.000208	0.000924	CcSEcCtD
Ponatinib—Decreased appetite—Timolol—migraine	0.000206	0.000912	CcSEcCtD
Ponatinib—CYP2C8—brain—migraine	0.000206	0.0019	CbGeAlD
Ponatinib—Gastrointestinal disorder—Timolol—migraine	0.000204	0.000906	CcSEcCtD
Ponatinib—Fatigue—Timolol—migraine	0.000204	0.000905	CcSEcCtD
Ponatinib—Leukopenia—Topiramate—migraine	0.000204	0.000902	CcSEcCtD
Ponatinib—Pain—Timolol—migraine	0.000203	0.000898	CcSEcCtD
Ponatinib—ABCB1—cardiovascular system—migraine	0.000201	0.00186	CbGeAlD
Ponatinib—Musculoskeletal discomfort—Gabapentin—migraine	0.000201	0.000891	CcSEcCtD
Ponatinib—ABCG2—brain—migraine	0.0002	0.00185	CbGeAlD
Ponatinib—Insomnia—Gabapentin—migraine	0.000199	0.000884	CcSEcCtD
Ponatinib—Cough—Topiramate—migraine	0.000198	0.000879	CcSEcCtD
Ponatinib—Paraesthesia—Gabapentin—migraine	0.000198	0.000878	CcSEcCtD
Ponatinib—Dyspnoea—Gabapentin—migraine	0.000197	0.000871	CcSEcCtD
Ponatinib—Hypertension—Topiramate—migraine	0.000196	0.00087	CcSEcCtD
Ponatinib—Dyspepsia—Gabapentin—migraine	0.000194	0.00086	CcSEcCtD
Ponatinib—Gastrointestinal pain—Timolol—migraine	0.000194	0.000858	CcSEcCtD
Ponatinib—Arthralgia—Topiramate—migraine	0.000194	0.000858	CcSEcCtD
Ponatinib—Myalgia—Topiramate—migraine	0.000194	0.000858	CcSEcCtD
Ponatinib—Unspecified disorder of skin and subcutaneous tissue—Topiramate—migraine	0.000192	0.000852	CcSEcCtD
Ponatinib—Decreased appetite—Gabapentin—migraine	0.000192	0.00085	CcSEcCtD
Ponatinib—Asthenia—Valproic Acid—migraine	0.000191	0.000846	CcSEcCtD
Ponatinib—Gastrointestinal disorder—Gabapentin—migraine	0.00019	0.000844	CcSEcCtD
Ponatinib—Fatigue—Gabapentin—migraine	0.00019	0.000843	CcSEcCtD
Ponatinib—Dry mouth—Topiramate—migraine	0.000189	0.000839	CcSEcCtD
Ponatinib—CYP2D6—head—migraine	0.000189	0.00175	CbGeAlD
Ponatinib—Pain—Gabapentin—migraine	0.000189	0.000836	CcSEcCtD
Ponatinib—Constipation—Gabapentin—migraine	0.000189	0.000836	CcSEcCtD
Ponatinib—Pruritus—Valproic Acid—migraine	0.000188	0.000834	CcSEcCtD
Ponatinib—Body temperature increased—Timolol—migraine	0.000187	0.00083	CcSEcCtD
Ponatinib—Abdominal pain—Timolol—migraine	0.000187	0.00083	CcSEcCtD
Ponatinib—Oedema—Topiramate—migraine	0.000186	0.000822	CcSEcCtD
Ponatinib—Infection—Topiramate—migraine	0.000184	0.000817	CcSEcCtD
Ponatinib—CYP3A4—nervous system—migraine	0.000182	0.00168	CbGeAlD
Ponatinib—Diarrhoea—Valproic Acid—migraine	0.000182	0.000807	CcSEcCtD
Ponatinib—Nervous system disorder—Topiramate—migraine	0.000182	0.000807	CcSEcCtD
Ponatinib—Thrombocytopenia—Topiramate—migraine	0.000182	0.000805	CcSEcCtD
Ponatinib—Gastrointestinal pain—Gabapentin—migraine	0.00018	0.000799	CcSEcCtD
Ponatinib—Skin disorder—Topiramate—migraine	0.00018	0.000799	CcSEcCtD
Ponatinib—CYP2D6—nervous system—migraine	0.000179	0.00166	CbGeAlD
Ponatinib—Hyperhidrosis—Topiramate—migraine	0.000179	0.000795	CcSEcCtD
Ponatinib—Dizziness—Valproic Acid—migraine	0.000176	0.00078	CcSEcCtD
Ponatinib—CYP3A4—central nervous system—migraine	0.000176	0.00162	CbGeAlD
Ponatinib—Abdominal pain—Gabapentin—migraine	0.000174	0.000773	CcSEcCtD
Ponatinib—Body temperature increased—Gabapentin—migraine	0.000174	0.000773	CcSEcCtD
Ponatinib—CYP2D6—central nervous system—migraine	0.000173	0.0016	CbGeAlD
Ponatinib—Asthenia—Timolol—migraine	0.00017	0.000753	CcSEcCtD
Ponatinib—Vomiting—Valproic Acid—migraine	0.000169	0.00075	CcSEcCtD
Ponatinib—Musculoskeletal discomfort—Topiramate—migraine	0.000169	0.000749	CcSEcCtD
Ponatinib—CYP2D6—cerebellum—migraine	0.000169	0.00156	CbGeAlD
Ponatinib—Insomnia—Topiramate—migraine	0.000168	0.000744	CcSEcCtD
Ponatinib—Rash—Valproic Acid—migraine	0.000168	0.000743	CcSEcCtD
Ponatinib—Dermatitis—Valproic Acid—migraine	0.000168	0.000743	CcSEcCtD
Ponatinib—Pruritus—Timolol—migraine	0.000168	0.000743	CcSEcCtD
Ponatinib—Headache—Valproic Acid—migraine	0.000167	0.000739	CcSEcCtD
Ponatinib—Paraesthesia—Topiramate—migraine	0.000167	0.000738	CcSEcCtD
Ponatinib—Dyspnoea—Topiramate—migraine	0.000165	0.000733	CcSEcCtD
Ponatinib—Dyspepsia—Topiramate—migraine	0.000163	0.000724	CcSEcCtD
Ponatinib—Diarrhoea—Timolol—migraine	0.000162	0.000718	CcSEcCtD
Ponatinib—Decreased appetite—Topiramate—migraine	0.000161	0.000715	CcSEcCtD
Ponatinib—Gastrointestinal disorder—Topiramate—migraine	0.00016	0.00071	CcSEcCtD
Ponatinib—Fatigue—Topiramate—migraine	0.00016	0.000709	CcSEcCtD
Ponatinib—Constipation—Topiramate—migraine	0.000159	0.000703	CcSEcCtD
Ponatinib—Pain—Topiramate—migraine	0.000159	0.000703	CcSEcCtD
Ponatinib—Asthenia—Gabapentin—migraine	0.000158	0.000701	CcSEcCtD
Ponatinib—Nausea—Valproic Acid—migraine	0.000158	0.0007	CcSEcCtD
Ponatinib—Dizziness—Timolol—migraine	0.000157	0.000694	CcSEcCtD
Ponatinib—Pruritus—Gabapentin—migraine	0.000156	0.000692	CcSEcCtD
Ponatinib—Gastrointestinal pain—Topiramate—migraine	0.000152	0.000672	CcSEcCtD
Ponatinib—Diarrhoea—Gabapentin—migraine	0.000151	0.000669	CcSEcCtD
Ponatinib—Vomiting—Timolol—migraine	0.000151	0.000667	CcSEcCtD
Ponatinib—Rash—Timolol—migraine	0.000149	0.000662	CcSEcCtD
Ponatinib—Dermatitis—Timolol—migraine	0.000149	0.000661	CcSEcCtD
Ponatinib—Headache—Timolol—migraine	0.000148	0.000658	CcSEcCtD
Ponatinib—Abdominal pain—Topiramate—migraine	0.000147	0.00065	CcSEcCtD
Ponatinib—Body temperature increased—Topiramate—migraine	0.000147	0.00065	CcSEcCtD
Ponatinib—Dizziness—Gabapentin—migraine	0.000146	0.000646	CcSEcCtD
Ponatinib—Nausea—Timolol—migraine	0.000141	0.000624	CcSEcCtD
Ponatinib—Vomiting—Gabapentin—migraine	0.00014	0.000622	CcSEcCtD
Ponatinib—Rash—Gabapentin—migraine	0.000139	0.000616	CcSEcCtD
Ponatinib—Dermatitis—Gabapentin—migraine	0.000139	0.000616	CcSEcCtD
Ponatinib—Headache—Gabapentin—migraine	0.000138	0.000612	CcSEcCtD
Ponatinib—CYP2D6—brain—migraine	0.000137	0.00127	CbGeAlD
Ponatinib—ABCB1—head—migraine	0.000136	0.00126	CbGeAlD
Ponatinib—Asthenia—Topiramate—migraine	0.000133	0.00059	CcSEcCtD
Ponatinib—Pruritus—Topiramate—migraine	0.000131	0.000582	CcSEcCtD
Ponatinib—Nausea—Gabapentin—migraine	0.000131	0.000581	CcSEcCtD
Ponatinib—ABCB1—nervous system—migraine	0.000129	0.00119	CbGeAlD
Ponatinib—Diarrhoea—Topiramate—migraine	0.000127	0.000563	CcSEcCtD
Ponatinib—ABCB1—central nervous system—migraine	0.000124	0.00115	CbGeAlD
Ponatinib—Dizziness—Topiramate—migraine	0.000123	0.000544	CcSEcCtD
Ponatinib—ABCB1—cerebellum—migraine	0.000121	0.00112	CbGeAlD
Ponatinib—Vomiting—Topiramate—migraine	0.000118	0.000523	CcSEcCtD
Ponatinib—Rash—Topiramate—migraine	0.000117	0.000519	CcSEcCtD
Ponatinib—Dermatitis—Topiramate—migraine	0.000117	0.000518	CcSEcCtD
Ponatinib—Headache—Topiramate—migraine	0.000116	0.000515	CcSEcCtD
Ponatinib—Nausea—Topiramate—migraine	0.00011	0.000488	CcSEcCtD
Ponatinib—ABCB1—brain—migraine	9.87e-05	0.000911	CbGeAlD
Ponatinib—SRC—EGF/EGFR Signaling Pathway—FOS—migraine	7.06e-05	0.00108	CbGpPWpGaD
Ponatinib—FGFR4—Disease—TGFBR2—migraine	6.98e-05	0.00106	CbGpPWpGaD
Ponatinib—FGFR4—Signaling Pathways—HTR1B—migraine	6.97e-05	0.00106	CbGpPWpGaD
Ponatinib—FGFR3—Signaling Pathways—LRP1—migraine	6.97e-05	0.00106	CbGpPWpGaD
Ponatinib—BCR—Signaling Pathways—TGFBR2—migraine	6.94e-05	0.00106	CbGpPWpGaD
Ponatinib—KDR—Signaling Pathways—HTR2B—migraine	6.89e-05	0.00105	CbGpPWpGaD
Ponatinib—SRC—Integrated Pancreatic Cancer Pathway—ESR1—migraine	6.87e-05	0.00105	CbGpPWpGaD
Ponatinib—FGFR2—Disease—LRP1—migraine	6.84e-05	0.00104	CbGpPWpGaD
Ponatinib—KIT—Disease—LRP1—migraine	6.72e-05	0.00102	CbGpPWpGaD
Ponatinib—FGFR4—Signaling Pathways—HTR1A—migraine	6.71e-05	0.00102	CbGpPWpGaD
Ponatinib—FGFR4—Signaling Pathways—TAC1—migraine	6.61e-05	0.00101	CbGpPWpGaD
Ponatinib—FGFR4—Signaling Pathways—NPS—migraine	6.61e-05	0.00101	CbGpPWpGaD
Ponatinib—FGFR4—Signaling Pathways—PGR—migraine	6.61e-05	0.00101	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—RAMP1—migraine	6.61e-05	0.00101	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—CALCRL—migraine	6.61e-05	0.00101	CbGpPWpGaD
Ponatinib—FGFR4—Signaling Pathways—HTR2C—migraine	6.48e-05	0.000987	CbGpPWpGaD
Ponatinib—ABCB1—Transmembrane transport of small molecules—HTR3A—migraine	6.46e-05	0.000983	CbGpPWpGaD
Ponatinib—FGFR3—Disease—CALCA—migraine	6.41e-05	0.000976	CbGpPWpGaD
Ponatinib—FGFR1—Disease—LRP1—migraine	6.38e-05	0.000971	CbGpPWpGaD
Ponatinib—PDGFRA—Disease—LRP1—migraine	6.36e-05	0.000969	CbGpPWpGaD
Ponatinib—FGFR4—Signaling Pathways—EDNRA—migraine	6.31e-05	0.00096	CbGpPWpGaD
Ponatinib—FGFR3—Innate Immune System—FOS—migraine	6.25e-05	0.000951	CbGpPWpGaD
Ponatinib—FGFR4—Signaling Pathways—NOTCH3—migraine	6.15e-05	0.000936	CbGpPWpGaD
Ponatinib—KDR—Signaling Pathways—LRP1—migraine	6.07e-05	0.000924	CbGpPWpGaD
Ponatinib—FGFR4—Signaling Pathways—CALCA—migraine	6.07e-05	0.000924	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—HTR1D—migraine	5.86e-05	0.000891	CbGpPWpGaD
Ponatinib—FGFR1—MAPK Signaling Pathway—TNF—migraine	5.78e-05	0.00088	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—HTR1D—migraine	5.75e-05	0.000875	CbGpPWpGaD
Ponatinib—FGFR4—Signaling Pathways—HTR7—migraine	5.68e-05	0.000864	CbGpPWpGaD
Ponatinib—FGFR4—Disease—MTHFR—migraine	5.67e-05	0.000863	CbGpPWpGaD
Ponatinib—BCR—Signaling Pathways—HTR2A—migraine	5.64e-05	0.000859	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—HTR1D—migraine	5.46e-05	0.000831	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—HTR1D—migraine	5.44e-05	0.000829	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—HTR2B—migraine	5.44e-05	0.000829	CbGpPWpGaD
Ponatinib—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—migraine	5.42e-05	0.000825	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—RAMP1—migraine	5.42e-05	0.000825	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—CALCRL—migraine	5.42e-05	0.000825	CbGpPWpGaD
Ponatinib—FGFR3—Signaling Pathways—NOTCH4—migraine	5.35e-05	0.000814	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—HTR2B—migraine	5.35e-05	0.000814	CbGpPWpGaD
Ponatinib—FGFR1—Integrated Pancreatic Cancer Pathway—TNF—migraine	5.21e-05	0.000794	CbGpPWpGaD
Ponatinib—PDGFRA—Integrated Pancreatic Cancer Pathway—TNF—migraine	5.2e-05	0.000792	CbGpPWpGaD
Ponatinib—FGFR3—Disease—TGFBR2—migraine	5.17e-05	0.000786	CbGpPWpGaD
Ponatinib—FGFR3—Signaling Pathways—HTR1B—migraine	5.16e-05	0.000785	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—HTR2B—migraine	5.07e-05	0.000772	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—HTR2B—migraine	5.06e-05	0.00077	CbGpPWpGaD
Ponatinib—BCR—Signaling Pathways—ESR1—migraine	5.01e-05	0.000763	CbGpPWpGaD
Ponatinib—FGFR3—Signaling Pathways—HTR1A—migraine	4.97e-05	0.000756	CbGpPWpGaD
Ponatinib—FGFR4—Immune System—FOS—migraine	4.92e-05	0.000749	CbGpPWpGaD
Ponatinib—FGFR4—Signaling Pathways—TGFBR2—migraine	4.89e-05	0.000744	CbGpPWpGaD
Ponatinib—FGFR3—Signaling Pathways—TAC1—migraine	4.89e-05	0.000744	CbGpPWpGaD
Ponatinib—FGFR3—Signaling Pathways—PGR—migraine	4.89e-05	0.000744	CbGpPWpGaD
Ponatinib—FGFR3—Signaling Pathways—NPS—migraine	4.89e-05	0.000744	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—HTR1D—migraine	4.8e-05	0.000731	CbGpPWpGaD
Ponatinib—FGFR3—Signaling Pathways—HTR2C—migraine	4.8e-05	0.00073	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—RAMP1—migraine	4.8e-05	0.00073	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—CALCRL—migraine	4.8e-05	0.00073	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—LRP1—migraine	4.79e-05	0.00073	CbGpPWpGaD
Ponatinib—ABCG2—Metabolism—CACNA1A—migraine	4.76e-05	0.000724	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—LRP1—migraine	4.71e-05	0.000717	CbGpPWpGaD
Ponatinib—FGFR3—Signaling Pathways—EDNRA—migraine	4.66e-05	0.00071	CbGpPWpGaD
Ponatinib—KDR—Signaling Pathways—NOTCH4—migraine	4.66e-05	0.000709	CbGpPWpGaD
Ponatinib—LCK—Disease—LRP1—migraine	4.6e-05	0.0007	CbGpPWpGaD
Ponatinib—ABL1—Integrated Pancreatic Cancer Pathway—TNF—migraine	4.57e-05	0.000695	CbGpPWpGaD
Ponatinib—FGFR3—Signaling Pathways—NOTCH3—migraine	4.55e-05	0.000692	CbGpPWpGaD
Ponatinib—KDR—Signaling Pathways—HTR1B—migraine	4.49e-05	0.000684	CbGpPWpGaD
Ponatinib—FGFR3—Signaling Pathways—CALCA—migraine	4.49e-05	0.000684	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—LRP1—migraine	4.47e-05	0.00068	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—HTR2B—migraine	4.46e-05	0.00068	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—LRP1—migraine	4.46e-05	0.000678	CbGpPWpGaD
Ponatinib—FGFR2—Disease—CALCA—migraine	4.41e-05	0.000671	CbGpPWpGaD
Ponatinib—KIT—Disease—CALCA—migraine	4.33e-05	0.000659	CbGpPWpGaD
Ponatinib—KDR—Signaling Pathways—HTR1A—migraine	4.33e-05	0.000658	CbGpPWpGaD
Ponatinib—FGFR2—Innate Immune System—FOS—migraine	4.3e-05	0.000654	CbGpPWpGaD
Ponatinib—KDR—Signaling Pathways—TAC1—migraine	4.26e-05	0.000648	CbGpPWpGaD
Ponatinib—KDR—Signaling Pathways—NPS—migraine	4.26e-05	0.000648	CbGpPWpGaD
Ponatinib—KDR—Signaling Pathways—PGR—migraine	4.26e-05	0.000648	CbGpPWpGaD
Ponatinib—KIT—Innate Immune System—FOS—migraine	4.22e-05	0.000643	CbGpPWpGaD
Ponatinib—FGFR3—Signaling Pathways—HTR7—migraine	4.2e-05	0.000639	CbGpPWpGaD
Ponatinib—FGFR3—Disease—MTHFR—migraine	4.19e-05	0.000639	CbGpPWpGaD
Ponatinib—KDR—Signaling Pathways—HTR2C—migraine	4.18e-05	0.000636	CbGpPWpGaD
Ponatinib—FGFR1—Disease—CALCA—migraine	4.11e-05	0.000626	CbGpPWpGaD
Ponatinib—PDGFRA—Disease—CALCA—migraine	4.1e-05	0.000624	CbGpPWpGaD
Ponatinib—SRC—Disease—LRP1—migraine	4.07e-05	0.00062	CbGpPWpGaD
Ponatinib—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—migraine	4.07e-05	0.000619	CbGpPWpGaD
Ponatinib—KDR—Signaling Pathways—EDNRA—migraine	4.06e-05	0.000619	CbGpPWpGaD
Ponatinib—FGFR1—Innate Immune System—FOS—migraine	4.01e-05	0.00061	CbGpPWpGaD
Ponatinib—PDGFRA—Innate Immune System—FOS—migraine	4e-05	0.000608	CbGpPWpGaD
Ponatinib—ABCB1—Allograft Rejection—TNF—migraine	3.99e-05	0.000608	CbGpPWpGaD
Ponatinib—FGFR4—Signaling Pathways—HTR2A—migraine	3.98e-05	0.000605	CbGpPWpGaD
Ponatinib—KDR—Signaling Pathways—NOTCH3—migraine	3.96e-05	0.000603	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—HTR1D—migraine	3.94e-05	0.000599	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—LRP1—migraine	3.93e-05	0.000598	CbGpPWpGaD
Ponatinib—KDR—Signaling Pathways—CALCA—migraine	3.91e-05	0.000595	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—NOTCH4—migraine	3.68e-05	0.00056	CbGpPWpGaD
Ponatinib—KDR—Signaling Pathways—HTR7—migraine	3.66e-05	0.000557	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—HTR2B—migraine	3.66e-05	0.000557	CbGpPWpGaD
Ponatinib—FGFR3—Immune System—FOS—migraine	3.64e-05	0.000554	CbGpPWpGaD
Ponatinib—FGFR3—Signaling Pathways—TGFBR2—migraine	3.62e-05	0.000551	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—NOTCH4—migraine	3.61e-05	0.00055	CbGpPWpGaD
Ponatinib—FGFR2—Disease—TGFBR2—migraine	3.55e-05	0.000541	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—HTR1B—migraine	3.55e-05	0.00054	CbGpPWpGaD
Ponatinib—FGFR4—Signaling Pathways—ESR1—migraine	3.53e-05	0.000537	CbGpPWpGaD
Ponatinib—LYN—Innate Immune System—FOS—migraine	3.52e-05	0.000537	CbGpPWpGaD
Ponatinib—ABL1—Innate Immune System—FOS—migraine	3.51e-05	0.000534	CbGpPWpGaD
Ponatinib—KIT—Disease—TGFBR2—migraine	3.49e-05	0.000531	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—HTR1B—migraine	3.48e-05	0.00053	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—HTR1D—migraine	3.48e-05	0.00053	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—NOTCH4—migraine	3.43e-05	0.000522	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—NOTCH4—migraine	3.42e-05	0.00052	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—HTR1A—migraine	3.41e-05	0.00052	CbGpPWpGaD
Ponatinib—CYP3A5—Metabolism—CACNA1A—migraine	3.41e-05	0.000519	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—PGR—migraine	3.36e-05	0.000512	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—NPS—migraine	3.36e-05	0.000512	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—TAC1—migraine	3.36e-05	0.000512	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—HTR1A—migraine	3.35e-05	0.000511	CbGpPWpGaD
Ponatinib—SRC—Integrated Pancreatic Cancer Pathway—TNF—migraine	3.33e-05	0.000507	CbGpPWpGaD
Ponatinib—KDR—Developmental Biology—TNF—migraine	3.31e-05	0.000504	CbGpPWpGaD
Ponatinib—FGFR1—Disease—TGFBR2—migraine	3.31e-05	0.000504	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—HTR1B—migraine	3.31e-05	0.000503	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—PGR—migraine	3.3e-05	0.000503	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—NPS—migraine	3.3e-05	0.000503	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—TAC1—migraine	3.3e-05	0.000503	CbGpPWpGaD
Ponatinib—PDGFRA—Disease—TGFBR2—migraine	3.3e-05	0.000503	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—HTR1B—migraine	3.3e-05	0.000502	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—HTR2C—migraine	3.3e-05	0.000502	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—HTR2B—migraine	3.24e-05	0.000493	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—HTR2C—migraine	3.24e-05	0.000493	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—LRP1—migraine	3.22e-05	0.00049	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—EDNRA—migraine	3.21e-05	0.000488	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—HTR1A—migraine	3.18e-05	0.000485	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—HTR1A—migraine	3.17e-05	0.000483	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—EDNRA—migraine	3.15e-05	0.00048	CbGpPWpGaD
Ponatinib—KDR—Signaling Pathways—TGFBR2—migraine	3.15e-05	0.00048	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—TAC1—migraine	3.13e-05	0.000477	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—PGR—migraine	3.13e-05	0.000477	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—NPS—migraine	3.13e-05	0.000477	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—NOTCH3—migraine	3.13e-05	0.000476	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—NPS—migraine	3.13e-05	0.000476	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—TAC1—migraine	3.13e-05	0.000476	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—PGR—migraine	3.13e-05	0.000476	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—CALCA—migraine	3.09e-05	0.00047	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—HTR2C—migraine	3.07e-05	0.000468	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—NOTCH3—migraine	3.07e-05	0.000467	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—HTR2C—migraine	3.07e-05	0.000467	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—CALCA—migraine	3.03e-05	0.000462	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—NOTCH4—migraine	3.02e-05	0.000459	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—EDNRA—migraine	2.99e-05	0.000455	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—EDNRA—migraine	2.98e-05	0.000454	CbGpPWpGaD
Ponatinib—LCK—Disease—CALCA—migraine	2.96e-05	0.000451	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism—CACNA1A—migraine	2.95e-05	0.000449	CbGpPWpGaD
Ponatinib—FGFR3—Signaling Pathways—HTR2A—migraine	2.94e-05	0.000448	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—NOTCH3—migraine	2.91e-05	0.000444	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—HTR1B—migraine	2.91e-05	0.000443	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—NOTCH3—migraine	2.91e-05	0.000442	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—HTR7—migraine	2.89e-05	0.00044	CbGpPWpGaD
Ponatinib—LCK—Innate Immune System—FOS—migraine	2.89e-05	0.00044	CbGpPWpGaD
Ponatinib—FGFR2—Disease—MTHFR—migraine	2.89e-05	0.000439	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—CALCA—migraine	2.88e-05	0.000438	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—CALCA—migraine	2.87e-05	0.000437	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—LRP1—migraine	2.85e-05	0.000434	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—HTR7—migraine	2.84e-05	0.000432	CbGpPWpGaD
Ponatinib—KIT—Disease—MTHFR—migraine	2.83e-05	0.000431	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—HTR1A—migraine	2.8e-05	0.000426	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—NPS—migraine	2.76e-05	0.00042	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—PGR—migraine	2.76e-05	0.00042	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—TAC1—migraine	2.76e-05	0.00042	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—HTR2C—migraine	2.7e-05	0.000412	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—HTR7—migraine	2.69e-05	0.00041	CbGpPWpGaD
Ponatinib—FGFR1—Disease—MTHFR—migraine	2.69e-05	0.000409	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—HTR7—migraine	2.69e-05	0.000409	CbGpPWpGaD
Ponatinib—PDGFRA—Disease—MTHFR—migraine	2.68e-05	0.000408	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—EDNRA—migraine	2.63e-05	0.000401	CbGpPWpGaD
Ponatinib—SRC—Disease—CALCA—migraine	2.62e-05	0.000399	CbGpPWpGaD
Ponatinib—FGFR3—Signaling Pathways—ESR1—migraine	2.61e-05	0.000397	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—CACNA1A—migraine	2.57e-05	0.000391	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—NOTCH3—migraine	2.56e-05	0.00039	CbGpPWpGaD
Ponatinib—KDR—Signaling Pathways—HTR2A—migraine	2.56e-05	0.00039	CbGpPWpGaD
Ponatinib—SRC—Innate Immune System—FOS—migraine	2.56e-05	0.000389	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—CALCA—migraine	2.53e-05	0.000386	CbGpPWpGaD
Ponatinib—FGFR2—Immune System—FOS—migraine	2.5e-05	0.000381	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—TGFBR2—migraine	2.49e-05	0.000379	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—NOTCH4—migraine	2.47e-05	0.000376	CbGpPWpGaD
Ponatinib—KIT—Immune System—FOS—migraine	2.46e-05	0.000374	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—TGFBR2—migraine	2.44e-05	0.000372	CbGpPWpGaD
Ponatinib—FGFR1—Developmental Biology—TNF—migraine	2.44e-05	0.000371	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—CACNA1A—migraine	2.42e-05	0.000369	CbGpPWpGaD
Ponatinib—LCK—Disease—TGFBR2—migraine	2.39e-05	0.000363	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—HTR1B—migraine	2.38e-05	0.000363	CbGpPWpGaD
Ponatinib—ABCB11—Metabolism—MTHFR—migraine	2.38e-05	0.000362	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—HTR7—migraine	2.37e-05	0.000361	CbGpPWpGaD
Ponatinib—FGFR1—Immune System—FOS—migraine	2.33e-05	0.000355	CbGpPWpGaD
Ponatinib—PDGFRA—Immune System—FOS—migraine	2.33e-05	0.000354	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—TGFBR2—migraine	2.32e-05	0.000353	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—TGFBR2—migraine	2.31e-05	0.000352	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—HTR1A—migraine	2.3e-05	0.000349	CbGpPWpGaD
Ponatinib—KDR—Signaling Pathways—ESR1—migraine	2.27e-05	0.000346	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—TAC1—migraine	2.26e-05	0.000344	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—NPS—migraine	2.26e-05	0.000344	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—PGR—migraine	2.26e-05	0.000344	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—HTR2C—migraine	2.22e-05	0.000337	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—NOTCH4—migraine	2.19e-05	0.000333	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—EDNRA—migraine	2.16e-05	0.000328	CbGpPWpGaD
Ponatinib—LYN—Developmental Biology—TNF—migraine	2.15e-05	0.000327	CbGpPWpGaD
Ponatinib—ABL1—Developmental Biology—TNF—migraine	2.14e-05	0.000325	CbGpPWpGaD
Ponatinib—SRC—Disease—TGFBR2—migraine	2.11e-05	0.000322	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—HTR1B—migraine	2.11e-05	0.000321	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—NOTCH3—migraine	2.1e-05	0.00032	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—CALCA—migraine	2.08e-05	0.000316	CbGpPWpGaD
Ponatinib—LYN—Immune System—FOS—migraine	2.05e-05	0.000312	CbGpPWpGaD
Ponatinib—ABL1—Immune System—FOS—migraine	2.04e-05	0.000311	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—TGFBR2—migraine	2.04e-05	0.000311	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—HTR1A—migraine	2.03e-05	0.000309	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—HTR2A—migraine	2.02e-05	0.000308	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—PGR—migraine	2e-05	0.000305	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—TAC1—migraine	2e-05	0.000305	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—NPS—migraine	2e-05	0.000305	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—HTR2A—migraine	1.99e-05	0.000302	CbGpPWpGaD
Ponatinib—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—migraine	1.97e-05	0.0003	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—HTR2C—migraine	1.96e-05	0.000299	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—HTR7—migraine	1.94e-05	0.000296	CbGpPWpGaD
Ponatinib—LCK—Disease—MTHFR—migraine	1.94e-05	0.000295	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—EDNRA—migraine	1.91e-05	0.000291	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—HTR2A—migraine	1.89e-05	0.000287	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—HTR2A—migraine	1.88e-05	0.000286	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—NOTCH3—migraine	1.86e-05	0.000283	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—CALCA—migraine	1.84e-05	0.00028	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—ESR1—migraine	1.8e-05	0.000273	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—ESR1—migraine	1.76e-05	0.000268	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—HTR7—migraine	1.72e-05	0.000262	CbGpPWpGaD
Ponatinib—SRC—Disease—MTHFR—migraine	1.72e-05	0.000261	CbGpPWpGaD
Ponatinib—LCK—Immune System—FOS—migraine	1.68e-05	0.000256	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—ESR1—migraine	1.67e-05	0.000255	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—TGFBR2—migraine	1.67e-05	0.000255	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—ESR1—migraine	1.67e-05	0.000254	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—HTR2A—migraine	1.66e-05	0.000253	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—CACNA1A—migraine	1.58e-05	0.000241	CbGpPWpGaD
Ponatinib—ABCG2—Metabolism—MTHFR—migraine	1.57e-05	0.00024	CbGpPWpGaD
Ponatinib—SRC—Developmental Biology—TNF—migraine	1.56e-05	0.000237	CbGpPWpGaD
Ponatinib—SRC—Immune System—FOS—migraine	1.49e-05	0.000227	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—TGFBR2—migraine	1.48e-05	0.000225	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—ESR1—migraine	1.47e-05	0.000224	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—HTR2A—migraine	1.36e-05	0.000207	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—ESR1—migraine	1.21e-05	0.000184	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—HTR2A—migraine	1.2e-05	0.000183	CbGpPWpGaD
Ponatinib—CYP3A5—Metabolism—MTHFR—migraine	1.13e-05	0.000172	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—ESR1—migraine	1.07e-05	0.000163	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism—MTHFR—migraine	9.76e-06	0.000149	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—MTHFR—migraine	8.51e-06	0.000129	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—MTHFR—migraine	8.02e-06	0.000122	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—MTHFR—migraine	5.24e-06	7.98e-05	CbGpPWpGaD
